Sinohealth Technology Holdings Limited (Sinohealth Tech) filed its Monthly Return for Equity Issuer for the period ended 30 September 2026, confirming that both authorised and issued share capital remained unchanged during the month.
Authorised and Issued Capital • Authorised share capital stood at 2.00 billion ordinary shares with a par value of USD 0.01 each, representing total authorised capital of USD 20.00 million. • Issued shares (excluding treasury shares) were unchanged at 451.77 million. No treasury shares were held or cancelled, and no new shares were issued or repurchased.
Public Float Compliance • Shares held by the public accounted for 15.46 % of total issued shares. The company confirmed compliance with Hong Kong Stock Exchange public-float requirements.
Equity Incentive Schemes • No share options were exercised during the month, leaving outstanding options at zero. • The existing share option scheme allows for up to 45.00 million shares to be issued upon future grants and exercises.
Other Securities • The company reported no outstanding warrants, convertible securities or other equity-linked instruments, and no movements in treasury shares.
Governance Confirmation • The filing was signed by Executive Director Mr Wu Yushu on 7 October 2026, affirming the accuracy of disclosures.
Overall, Sinohealth Tech’s September return indicates a period of capital stability with full adherence to listing rules and adequate public float levels.
Comments